K J. Pasi

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.

Journal: The New England journal of medicine

Published: February 22, 2023

Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.

Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.

Journal: Blood advances

Published: October 27, 2022

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.

Journal: The New England journal of medicine

Published: March 16, 2022

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies.

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies.

Journal: Research and practice in thrombosis and haemostasis

Published: October 21, 2021

Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A.

Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A.

Journal: Nature medicine

Published: April 29, 2021

Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A.

Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 02, 2021

Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre's readiness in United States and EU.

Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre's readiness in United States and EU.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 16, 2020

Efficacy of Nuwiq® (Simoctocog Alfa) in Patients with Hemophilia A Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq Study.

Efficacy of Nuwiq® (Simoctocog Alfa) in Patients with Hemophilia A Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq Study.

Journal: Clinical medicine insights. Blood disorders

Published: November 24, 2020

Recombinant factor VIII Fc for the treatment of haemophilia A.

Recombinant factor VIII Fc for the treatment of haemophilia A.

Journal: European journal of haematology

Published: October 27, 2020

Lupus Anticoagulant in Patients with Covid-19. Reply.

Lupus Anticoagulant in Patients with Covid-19. Reply.

Journal: The New England journal of medicine

Published: October 23, 2020

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.

Journal: The New England journal of medicine

Published: May 06, 2020

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort.

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 24, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026